Michael Brennan to Mouth Mucosa
This is a "connection" page, showing publications Michael Brennan has written about Mouth Mucosa.
Connection Strength
1.376
-
Issa B, Padilla R, Brennan MT. Diagnosis and management of mucosal lesions with the potential for malignant transformation. J Calif Dent Assoc. 2013 May; 41(5):343-8.
Score: 0.442
-
Mougeot JL, Bahrani-Mougeot FK, Lockhart PB, Brennan MT. Microarray analyses of oral punch biopsies from acute myeloid leukemia (AML) patients treated with chemotherapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2011 Oct; 112(4):446-52.
Score: 0.395
-
Mougeot JL, Mougeot FK, Peterson DE, Padilla RJ, Brennan MT, Lockhart PB. Use of archived biopsy specimens to study gene expression in oral mucosa from chemotherapy-treated cancer patients. Oral Surg Oral Med Oral Pathol Oral Radiol. 2013 May; 115(5):630-7.
Score: 0.110
-
Rouleau TS, Manookin KM, Brennan MT. Restricted mouth opening. J Am Dent Assoc. 2012 Jul; 143(7):767-70.
Score: 0.104
-
Napeñas JJ, Brennan MT, Coleman S, Kent ML, Noll J, Frenette G, Nussbaum ML, Mougeot JL, Paster BJ, Lockhart PB, Bahrani-Mougeot FK. Molecular methodology to assess the impact of cancer chemotherapy on the oral bacterial flora: a pilot study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Apr; 109(4):554-60.
Score: 0.089
-
Thelin WR, Brennan MT, Lockhart PB, Singh ML, Fox PC, Papas AS, Boucher RC. The oral mucosa as a therapeutic target for xerostomia. Oral Dis. 2008 Nov; 14(8):683-9.
Score: 0.081
-
Brennan MT, Shariff G, Kent ML, Fox PC, Lockhart PB. Relationship between bleeding time test and postextraction bleeding in a healthy control population. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002 Oct; 94(4):439-43.
Score: 0.053
-
Mougeot JC, Stevens CB, Morton DS, Brennan MT, Mougeot FB. Oral Microbiome and Cancer Therapy-Induced Oral Mucositis. J Natl Cancer Inst Monogr. 2019 08 01; 2019(53).
Score: 0.043
-
Limaye SA, Haddad RI, Cilli F, Sonis ST, Colevas AD, Brennan MT, Hu KS, Murphy BA. Phase 1b, multicenter, single blinded, placebo-controlled, sequential dose escalation study to assess the safety and tolerability of topically applied AG013 in subjects with locally advanced head and neck cancer receiving induction chemotherapy. Cancer. 2013 Dec 15; 119(24):4268-76.
Score: 0.028
-
Nicopoulos M, Brennan MT, Kent ML, Brickhouse TH, Rogers MK, Fox PC, Lockhart PB. Oral health needs and barriers to dental care in hospitalized children. Spec Care Dentist. 2007 Sep-Oct; 27(5):206-11.
Score: 0.019
-
Baccaglini L, Schiffmann R, Brennan MT, Lancaster HE, Kulkarni AB, Brahim JS. Oral and craniofacial findings in Fabry's disease: a report of 13 patients. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2001 Oct; 92(4):415-9.
Score: 0.012